U.S. Software Stock News

Despite an already strong run, Moderna, Inc. ( NASDAQ:MRNA ) shares have been powering on, with a gain of 43% in the...

Unfortunately for some shareholders, the The Oncology Institute, Inc. ( NASDAQ:TOI ) share price has dived 26% in the...

The latest analyst coverage could presage a bad day for BKV Corporation ( NYSE:BKV ), with the analysts making...

Nomad Foods Limited ( NYSE:NOMD ) has announced that it will pay a dividend of €0.17 per share on the 26th of February...

Key Insights Significant control over Elong Power Holding by private equity firms implies that the general public has...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Fidelity National Information Services, Inc.'s ( NYSE:FIS ) dividend will be increasing from last year's payment of the...

You may think that with a price-to-sales (or "P/S") ratio of 0.3x TH International Limited ( NASDAQ:THCH ) is a stock...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Despite an already strong run, Neogen Corporation ( NASDAQ:NEOG ) shares have been powering on, with a gain of 46% in...

Rackspace Technology, Inc.'s (NASDAQ:RXT) value has fallen 20% in the last week, but insiders who sold US$57k worth of...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

The board of BlackRock, Inc. ( NYSE:BLK ) has announced that it will be paying its dividend of $5.73 on the 24th of...

Despite the fact that Bumble Inc.'s (NASDAQ:BMBL) value has dropped 14% in the last week insiders who sold US$2.3m...

Key Insights The considerable ownership by retail investors in Chaince Digital Holdings indicates that they...

Riskified Ltd. ( NYSE:RSKD ) is possibly approaching a major achievement in its business, so we would like to shine...

FDA approval for repeat iDose TR use reshapes the story Glaukos (GKOS) just secured FDA approval to allow repeat administration of its iDose TR implant, supported by clinical data demonstrating safety and tolerability. This directly addresses the needs of chronic glaucoma treatment and patient compliance. See our latest analysis for Glaukos. Glaukos shares trade at US$119.38 after a 30 day share price return of 7.82% and a 90 day share price return of 38.89%, while the 1 year total...

The Morning Bull - US Market Morning Update Monday, Feb, 2 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 0.7% and Nasdaq futures off roughly 1%, as investors react to weaker manufacturing signals and rising borrowing costs abroad. Across Europe, key manufacturing scorecards such as Italy’s and Spain’s PMIs are still below 50, which marks contraction and hints that factories are receiving fewer new orders and facing higher input costs,...

Blackstone Inc. ( NYSE:BX ) has announced that it will be increasing its dividend from last year's comparable payment...

Agree Realty (ADC) has drawn fresh attention after announcing a 3.6% increase in its monthly cash dividend and outlining a 2026 investment plan of up to US$1.5b for retail property acquisitions and developments. See our latest analysis for Agree Realty. At a share price of US$72.23, Agree Realty’s recent dividend increase and 2026 investment plan arrive after relatively muted share price movement over the past quarter. Its 1 year total shareholder return of 3.37% and 5 year total shareholder...

G-III Apparel Group (GIII) is back on investors’ radar after approving a quarterly dividend of US$0.10 per share and raising its fiscal 2026 earnings guidance following stronger-than-expected third quarter results. See our latest analysis for G-III Apparel Group. The dividend decision and upgraded fiscal 2026 guidance come as the share price trades at US$29.35, with a 9.03% 90 day share price return and a 77.69% three year total shareholder return. This suggests momentum has picked up...

Knight-Swift Transportation Holdings (KNX) just posted its fourth quarter 2025 results, reporting revenue of US$1,856.33 million and a net loss of US$6.8 million, compared with net income of US$69.5 million in the same period a year earlier. See our latest analysis for Knight-Swift Transportation Holdings. The weak fourth quarter and swing to a net loss sit against a share price of US$55.10, with a 90 day share price return of 23.02% and a 5 year total shareholder return of 39.16%. This...

Revolution Medicines recently dosed the first patient in its first-in-human trial of RMC-5127, an open-label study assessing safety, tolerability, pharmacokinetics and early antitumor activity in RAS G12V-mutated solid tumors after standard therapies have failed. The program targets RAS G12V, the second most common driver of RAS-addicted cancers in the US, affecting roughly 48,000 patients annually across pancreatic, colorectal and non-small cell lung cancers. We’ll now examine how the...

In recent months, Adecoagro has received a Zacks Rank #2 (Buy) as analysts sharply revised full-year earnings estimates higher and highlighted its value rating. What stands out is that Adecoagro’s valuation metrics, including P/E, PEG, P/B, and P/S ratios, compare favorably with its industry even as earnings expectations improve. We’ll now examine how this stronger earnings outlook, combined with favorable valuation ratios, shapes Adecoagro’s broader investment narrative for investors...